Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorChildren's Hospital Medical Center, Cincinnati
About this trial
The purpose of this research study is to document and understand the effects of hydroxyurea exposure for women with SCD and their babies, during both gestation and lactation.
Eligibility criteria
Qualifiers
Medical records or data available from previous clinical care prior to June 20, 2019 of pregnant females with SCD, including women who miscarried, had a still birth, or completed labor at any gestational stage, with any hydroxyurea exposure during either pregnancy and/or while breastfeeding.
Medical records or data available from previous clinical care prior to June 20, 2019 about pregnancy and breastfeeding outcomes, both for babies with hydroxyurea exposure and other babies by these same women.
Disqualifiers
Unavailable medical records or lack of information about hydroxyurea exposure.
Trial design
Treatments tested in this trial
- Chart Review
- Survey
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Children's Hospital Medical Center, Cincinnati
Lead sponsor
University of Connecticut
Collaborator
University of Colorado, Denver
Collaborator
Guy's and St Thomas' NHS Foundation Trust
Collaborator
Duke University
Collaborator
Children's Hospital of Philadelphia
Collaborator
Source ClinicalTrials.gov